Table 5.
Vaccination-dose effectiveness | Vaccination-strategy effectiveness | |||||
IRR | 95% CI | p-value | IRR | 95% CI | p-value | |
Model 1: univariate analysis | 1,37 | 0,60 -3,11 | 0,45 | 0,82 | 0,40 -1,69 | 0,59 |
Model 2: multiple analysis* | 0,51 | 0,22 -1,17 | 0,11 | 0,47 | 0,23 -0,98 | 0,04 |
Model 3: as model 2 but restricted to GA<32 weeks | 0,67 | 0,24 -1,85 | 0,44 | 0,65 | 0,26 -1,63 | 0,36 |
Model 4: as model 2 but restricted only to the epidemic period | 0,50 | 0,22 -1,14 | 0,10 | 0,49 | 0,24 -1,03 | 0,06 |
*adjusted for all covariates of table 3; GA = Gestational age